Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
21 June, 2018 12:07 IST
Strides Shasun gets USFDA nod for Potassium Citrate ER tablets
Source: IRIS | 12 Sep, 2017, 10.15AM
Comments  |  Post Comment

Strides Shasun has received approval from the United States Food & Drug Administration (USFDA) for Potassium Citrate Extended-Release Tablets USP, 5 mEq, 10 mEq, and 15 mEq.

According to IMS data, the US market for Potassium Citrate is approximately USD 110 million.

The company will be the second generic player to commercialize the product. The product, which is the first approval for an Extended Release tablet for the company, will be launched immediately.

Potassium Citrate, a urinary alkalinizing agent, is used for preventing certain types of kidney stones. It works by neutralizing some of the acid in the urine, which helps reduce the formation of crystals. 

Shares of the company gained Rs 28.7, or 3.05%, to trade at Rs 970.00. The total volume of shares traded was 46,320 at the BSE (9.58 a.m., Tuesday).



Strides Shasun Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Sector
Dilip Buildcon completes road project in Madhya Pradesh - 20-Jun-2018 16:06
BHEL wins Rs 10 bn orders for emission control equipment - 20-Jun-2018 13:38
Tata Comm wins contract from BlaBla Connect - 20-Jun-2018 12:51
Infosys opens digital center of excellence in France - 20-Jun-2018 10:13
Shreyas Shipping & Logistics takes delivery of vessel 'M.V. SSL Krishna' - 20-Jun-2018 10:09
ABB partners with Cochin Shipyard and Shipping Corporation of India - 20-Jun-2018 09:57
ABB partners with Cochin Shipyard and Shipping Corporation of India - 20-Jun-2018 09:57
Kansai Nerolac to enter into Bangladesh bv acquiring equity stake in RAK Paints - 20-Jun-2018 09:51
Sadbhav Infrastructure Project signs contract worth Rs 550 mn - 20-Jun-2018 09:46
Cipla receives final approval for generic Sustiva - 19-Jun-2018 16:22
Wind power tariffs sustainable around Rs 3 a unit: Crisil Research - 19-Jun-2018 12:28
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer